SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-047169
Filing Date
2013-10-03
Accepted
2013-10-03 16:22:44
Documents
1
Period of Report
2013-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3293
  Complete submission text file 0001209191-13-047169.txt   4950
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address STARCO CENTER BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT 2020-3313 M8 2020-3313
Business Address STARCO CENTER BLOC B, THIRD FLOOR OMAR DAOUK STREET BEIRUT 2020-3313 M8 2020-3313 9611363362
Abdul-Wahab Umari (Reporting) CIK: 0001562070 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 131134004